chikungunya virus child caps extent outbreak sever country within america asia oceanicpacif island europ human infect caps deficit disease act fabric ill longterm polyarthralgia chronic symptom impose major economy burden health system contribute poverty affect efficacy vaccine would import step toward decrease infect despite license yet avail strong revid effect asymptomatic viral clearance due neutral antibody structure protein design viralvector vaccine express use replicationdefici chimpanzee adenovir platform shadow express antigen result format viruslik partial induce high frequency antichikungunya specify cell response well tier antichikv e caps vitro neutral india potent clinic develop vaccinolog 